nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—ALB—multiple sclerosis	0.398	1	CbGaD
Prasugrel—ALB—Prednisone—multiple sclerosis	0.0569	0.147	CbGbCtD
Prasugrel—CYP3A4—Fingolimod—multiple sclerosis	0.0457	0.118	CbGbCtD
Prasugrel—CYP2C19—Prednisone—multiple sclerosis	0.0369	0.0954	CbGbCtD
Prasugrel—CYP2B6—Dexamethasone—multiple sclerosis	0.0362	0.0937	CbGbCtD
Prasugrel—CYP3A4—Methylprednisolone—multiple sclerosis	0.0294	0.0761	CbGbCtD
Prasugrel—ALB—Methotrexate—multiple sclerosis	0.0285	0.0738	CbGbCtD
Prasugrel—CYP2C19—Dexamethasone—multiple sclerosis	0.023	0.0596	CbGbCtD
Prasugrel—CYP3A4—Triamcinolone—multiple sclerosis	0.0223	0.0577	CbGbCtD
Prasugrel—CYP3A4—Mitoxantrone—multiple sclerosis	0.0215	0.0555	CbGbCtD
Prasugrel—CYP2C9—Dexamethasone—multiple sclerosis	0.0191	0.0495	CbGbCtD
Prasugrel—CYP3A4—Betamethasone—multiple sclerosis	0.0191	0.0495	CbGbCtD
Prasugrel—CYP3A4—Prednisolone—multiple sclerosis	0.0189	0.0488	CbGbCtD
Prasugrel—CYP3A4—Prednisone—multiple sclerosis	0.0178	0.0461	CbGbCtD
Prasugrel—CYP3A4—Dexamethasone—multiple sclerosis	0.0111	0.0288	CbGbCtD
Prasugrel—Back pain—Fingolimod—multiple sclerosis	0.00129	0.0102	CcSEcCtD
Prasugrel—Cerebrovascular accident—Cladribine—multiple sclerosis	0.00128	0.0101	CcSEcCtD
Prasugrel—Neoplasm—Azathioprine—multiple sclerosis	0.00127	0.01	CcSEcCtD
Prasugrel—Pain in extremity—Cladribine—multiple sclerosis	0.00125	0.00989	CcSEcCtD
Prasugrel—Leukopenia—Fingolimod—multiple sclerosis	0.00119	0.0094	CcSEcCtD
Prasugrel—Cough—Fingolimod—multiple sclerosis	0.00116	0.00917	CcSEcCtD
Prasugrel—Hypertension—Fingolimod—multiple sclerosis	0.00115	0.00907	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00112	0.00888	CcSEcCtD
Prasugrel—Skin disorder—Fingolimod—multiple sclerosis	0.00105	0.00833	CcSEcCtD
Prasugrel—Ecchymosis—Mitoxantrone—multiple sclerosis	0.00102	0.00809	CcSEcCtD
Prasugrel—Hypotension—Fingolimod—multiple sclerosis	0.00101	0.00801	CcSEcCtD
Prasugrel—Dyspnoea—Fingolimod—multiple sclerosis	0.000968	0.00764	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.000937	0.0074	CcSEcCtD
Prasugrel—Fatigue—Fingolimod—multiple sclerosis	0.000936	0.00739	CcSEcCtD
Prasugrel—Epistaxis—Cladribine—multiple sclerosis	0.00091	0.00719	CcSEcCtD
Prasugrel—Contusion—Betamethasone—multiple sclerosis	0.000889	0.00702	CcSEcCtD
Prasugrel—Contusion—Dexamethasone—multiple sclerosis	0.000889	0.00702	CcSEcCtD
Prasugrel—Haemoglobin—Cladribine—multiple sclerosis	0.00087	0.00687	CcSEcCtD
Prasugrel—Haemorrhage—Cladribine—multiple sclerosis	0.000866	0.00684	CcSEcCtD
Prasugrel—Urinary tract disorder—Cladribine—multiple sclerosis	0.000855	0.00676	CcSEcCtD
Prasugrel—Oedema peripheral—Cladribine—multiple sclerosis	0.000853	0.00674	CcSEcCtD
Prasugrel—Urethral disorder—Cladribine—multiple sclerosis	0.000849	0.00671	CcSEcCtD
Prasugrel—Ecchymosis—Prednisolone—multiple sclerosis	0.000841	0.00664	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Mitoxantrone—multiple sclerosis	0.000823	0.0065	CcSEcCtD
Prasugrel—Eye disorder—Cladribine—multiple sclerosis	0.000809	0.00639	CcSEcCtD
Prasugrel—Angiopathy—Cladribine—multiple sclerosis	0.000786	0.00621	CcSEcCtD
Prasugrel—Immune system disorder—Cladribine—multiple sclerosis	0.000782	0.00618	CcSEcCtD
Prasugrel—Mediastinal disorder—Cladribine—multiple sclerosis	0.00078	0.00616	CcSEcCtD
Prasugrel—Asthenia—Fingolimod—multiple sclerosis	0.000779	0.00615	CcSEcCtD
Prasugrel—Contusion—Prednisone—multiple sclerosis	0.000774	0.00612	CcSEcCtD
Prasugrel—Ecchymosis—Triamcinolone—multiple sclerosis	0.000773	0.00611	CcSEcCtD
Prasugrel—Ecchymosis—Methylprednisolone—multiple sclerosis	0.000771	0.00609	CcSEcCtD
Prasugrel—Diarrhoea—Fingolimod—multiple sclerosis	0.000743	0.00587	CcSEcCtD
Prasugrel—Back pain—Cladribine—multiple sclerosis	0.000729	0.00576	CcSEcCtD
Prasugrel—Dizziness—Fingolimod—multiple sclerosis	0.000718	0.00567	CcSEcCtD
Prasugrel—Hypercholesterolaemia—Prednisone—multiple sclerosis	0.000714	0.00564	CcSEcCtD
Prasugrel—Haemoglobin—Azathioprine—multiple sclerosis	0.000708	0.00559	CcSEcCtD
Prasugrel—Haemorrhage—Azathioprine—multiple sclerosis	0.000704	0.00556	CcSEcCtD
Prasugrel—Ecchymosis—Betamethasone—multiple sclerosis	0.000702	0.00554	CcSEcCtD
Prasugrel—Ecchymosis—Dexamethasone—multiple sclerosis	0.000702	0.00554	CcSEcCtD
Prasugrel—Anaemia—Cladribine—multiple sclerosis	0.000697	0.0055	CcSEcCtD
Prasugrel—Headache—Fingolimod—multiple sclerosis	0.00068	0.00537	CcSEcCtD
Prasugrel—Cough—Cladribine—multiple sclerosis	0.000658	0.0052	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.000637	0.00503	CcSEcCtD
Prasugrel—Immune system disorder—Azathioprine—multiple sclerosis	0.000636	0.00502	CcSEcCtD
Prasugrel—Mediastinal disorder—Azathioprine—multiple sclerosis	0.000635	0.00501	CcSEcCtD
Prasugrel—Ecchymosis—Prednisone—multiple sclerosis	0.000611	0.00483	CcSEcCtD
Prasugrel—Haematuria—Mitoxantrone—multiple sclerosis	0.000605	0.00478	CcSEcCtD
Prasugrel—Thrombocytopenia—Cladribine—multiple sclerosis	0.000602	0.00476	CcSEcCtD
Prasugrel—Skin disorder—Cladribine—multiple sclerosis	0.000598	0.00472	CcSEcCtD
Prasugrel—Bradycardia—Mitoxantrone—multiple sclerosis	0.000579	0.00458	CcSEcCtD
Prasugrel—Hypotension—Cladribine—multiple sclerosis	0.000575	0.00454	CcSEcCtD
Prasugrel—Haemoglobin—Mitoxantrone—multiple sclerosis	0.000572	0.00452	CcSEcCtD
Prasugrel—Haemorrhage—Mitoxantrone—multiple sclerosis	0.000569	0.0045	CcSEcCtD
Prasugrel—Anaemia—Azathioprine—multiple sclerosis	0.000566	0.00447	CcSEcCtD
Prasugrel—Leukopenia—Azathioprine—multiple sclerosis	0.000549	0.00433	CcSEcCtD
Prasugrel—Dyspnoea—Cladribine—multiple sclerosis	0.000548	0.00433	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000531	0.0042	CcSEcCtD
Prasugrel—Fatigue—Cladribine—multiple sclerosis	0.00053	0.00419	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000518	0.00409	CcSEcCtD
Prasugrel—Ecchymosis—Methotrexate—multiple sclerosis	0.000511	0.00403	CcSEcCtD
Prasugrel—Neoplasm—Methotrexate—multiple sclerosis	0.000511	0.00403	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Prednisone—multiple sclerosis	0.00049	0.00387	CcSEcCtD
Prasugrel—Thrombocytopenia—Azathioprine—multiple sclerosis	0.00049	0.00387	CcSEcCtD
Prasugrel—Body temperature increased—Cladribine—multiple sclerosis	0.000486	0.00384	CcSEcCtD
Prasugrel—Skin disorder—Azathioprine—multiple sclerosis	0.000486	0.00384	CcSEcCtD
Prasugrel—Back pain—Mitoxantrone—multiple sclerosis	0.000479	0.00379	CcSEcCtD
Prasugrel—Bradycardia—Prednisolone—multiple sclerosis	0.000475	0.00376	CcSEcCtD
Prasugrel—Haemoglobin—Prednisolone—multiple sclerosis	0.000469	0.00371	CcSEcCtD
Prasugrel—Hypotension—Azathioprine—multiple sclerosis	0.000467	0.00369	CcSEcCtD
Prasugrel—Haemorrhage—Prednisolone—multiple sclerosis	0.000467	0.00369	CcSEcCtD
Prasugrel—Anaemia—Mitoxantrone—multiple sclerosis	0.000458	0.00362	CcSEcCtD
Prasugrel—Hypersensitivity—Cladribine—multiple sclerosis	0.000453	0.00358	CcSEcCtD
Prasugrel—Epistaxis—Triamcinolone—multiple sclerosis	0.000451	0.00356	CcSEcCtD
Prasugrel—Leukopenia—Mitoxantrone—multiple sclerosis	0.000444	0.0035	CcSEcCtD
Prasugrel—Asthenia—Cladribine—multiple sclerosis	0.000441	0.00349	CcSEcCtD
Prasugrel—Bradycardia—Triamcinolone—multiple sclerosis	0.000437	0.00345	CcSEcCtD
Prasugrel—Bradycardia—Methylprednisolone—multiple sclerosis	0.000436	0.00345	CcSEcCtD
Prasugrel—Cough—Mitoxantrone—multiple sclerosis	0.000432	0.00342	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000432	0.00341	CcSEcCtD
Prasugrel—Haemoglobin—Triamcinolone—multiple sclerosis	0.000432	0.00341	CcSEcCtD
Prasugrel—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000431	0.0034	CcSEcCtD
Prasugrel—Haemorrhage—Triamcinolone—multiple sclerosis	0.000429	0.00339	CcSEcCtD
Prasugrel—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000428	0.00338	CcSEcCtD
Prasugrel—Hypertension—Mitoxantrone—multiple sclerosis	0.000428	0.00338	CcSEcCtD
Prasugrel—Diarrhoea—Cladribine—multiple sclerosis	0.000421	0.00333	CcSEcCtD
Prasugrel—Cerebrovascular accident—Methotrexate—multiple sclerosis	0.000418	0.0033	CcSEcCtD
Prasugrel—Dizziness—Cladribine—multiple sclerosis	0.000407	0.00321	CcSEcCtD
Prasugrel—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000404	0.00319	CcSEcCtD
Prasugrel—Eye disorder—Methylprednisolone—multiple sclerosis	0.0004	0.00316	CcSEcCtD
Prasugrel—Bradycardia—Dexamethasone—multiple sclerosis	0.000397	0.00313	CcSEcCtD
Prasugrel—Bradycardia—Betamethasone—multiple sclerosis	0.000397	0.00313	CcSEcCtD
Prasugrel—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000396	0.00313	CcSEcCtD
Prasugrel—Body temperature increased—Azathioprine—multiple sclerosis	0.000395	0.00312	CcSEcCtD
Prasugrel—Skin disorder—Mitoxantrone—multiple sclerosis	0.000393	0.0031	CcSEcCtD
Prasugrel—Haemoglobin—Betamethasone—multiple sclerosis	0.000392	0.00309	CcSEcCtD
Prasugrel—Haemoglobin—Dexamethasone—multiple sclerosis	0.000392	0.00309	CcSEcCtD
Prasugrel—Haemorrhage—Betamethasone—multiple sclerosis	0.00039	0.00308	CcSEcCtD
Prasugrel—Haemorrhage—Dexamethasone—multiple sclerosis	0.00039	0.00308	CcSEcCtD
Prasugrel—Angiopathy—Methylprednisolone—multiple sclerosis	0.000389	0.00307	CcSEcCtD
Prasugrel—Rash—Cladribine—multiple sclerosis	0.000388	0.00306	CcSEcCtD
Prasugrel—Dermatitis—Cladribine—multiple sclerosis	0.000388	0.00306	CcSEcCtD
Prasugrel—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000387	0.00306	CcSEcCtD
Prasugrel—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000386	0.00305	CcSEcCtD
Prasugrel—Headache—Cladribine—multiple sclerosis	0.000385	0.00304	CcSEcCtD
Prasugrel—Hypotension—Mitoxantrone—multiple sclerosis	0.000378	0.00298	CcSEcCtD
Prasugrel—Angioedema—Prednisolone—multiple sclerosis	0.000371	0.00293	CcSEcCtD
Prasugrel—Hypersensitivity—Azathioprine—multiple sclerosis	0.000369	0.00291	CcSEcCtD
Prasugrel—Nausea—Cladribine—multiple sclerosis	0.000365	0.00289	CcSEcCtD
Prasugrel—Eye disorder—Betamethasone—multiple sclerosis	0.000364	0.00288	CcSEcCtD
Prasugrel—Eye disorder—Dexamethasone—multiple sclerosis	0.000364	0.00288	CcSEcCtD
Prasugrel—Back pain—Triamcinolone—multiple sclerosis	0.000362	0.00286	CcSEcCtD
Prasugrel—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000361	0.00285	CcSEcCtD
Prasugrel—Angiopathy—Betamethasone—multiple sclerosis	0.000354	0.00279	CcSEcCtD
Prasugrel—Angiopathy—Dexamethasone—multiple sclerosis	0.000354	0.00279	CcSEcCtD
Prasugrel—Hypertension—Prednisolone—multiple sclerosis	0.000351	0.00277	CcSEcCtD
Prasugrel—Fatigue—Mitoxantrone—multiple sclerosis	0.000349	0.00275	CcSEcCtD
Prasugrel—Bradycardia—Prednisone—multiple sclerosis	0.000345	0.00273	CcSEcCtD
Prasugrel—Diarrhoea—Azathioprine—multiple sclerosis	0.000342	0.0027	CcSEcCtD
Prasugrel—Angioedema—Triamcinolone—multiple sclerosis	0.000342	0.0027	CcSEcCtD
Prasugrel—Haemoglobin—Prednisone—multiple sclerosis	0.000341	0.00269	CcSEcCtD
Prasugrel—Angioedema—Methylprednisolone—multiple sclerosis	0.000341	0.00269	CcSEcCtD
Prasugrel—Haemorrhage—Prednisone—multiple sclerosis	0.000339	0.00268	CcSEcCtD
Prasugrel—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000332	0.00262	CcSEcCtD
Prasugrel—Dizziness—Azathioprine—multiple sclerosis	0.000331	0.00261	CcSEcCtD
Prasugrel—Cough—Triamcinolone—multiple sclerosis	0.000326	0.00258	CcSEcCtD
Prasugrel—Hypertension—Triamcinolone—multiple sclerosis	0.000323	0.00255	CcSEcCtD
Prasugrel—Hypertension—Methylprednisolone—multiple sclerosis	0.000322	0.00254	CcSEcCtD
Prasugrel—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00032	0.00253	CcSEcCtD
Prasugrel—Eye disorder—Prednisone—multiple sclerosis	0.000317	0.0025	CcSEcCtD
Prasugrel—Rash—Azathioprine—multiple sclerosis	0.000315	0.00249	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000315	0.00249	CcSEcCtD
Prasugrel—Dermatitis—Azathioprine—multiple sclerosis	0.000315	0.00249	CcSEcCtD
Prasugrel—Headache—Azathioprine—multiple sclerosis	0.000313	0.00248	CcSEcCtD
Prasugrel—Angioedema—Dexamethasone—multiple sclerosis	0.00031	0.00245	CcSEcCtD
Prasugrel—Angioedema—Betamethasone—multiple sclerosis	0.00031	0.00245	CcSEcCtD
Prasugrel—Angiopathy—Prednisone—multiple sclerosis	0.000308	0.00243	CcSEcCtD
Prasugrel—Immune system disorder—Prednisone—multiple sclerosis	0.000306	0.00242	CcSEcCtD
Prasugrel—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000305	0.00241	CcSEcCtD
Prasugrel—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000304	0.0024	CcSEcCtD
Prasugrel—CYP2B6—Biological oxidations—CYP24A1—multiple sclerosis	0.000302	0.0034	CbGpPWpGaD
Prasugrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000301	0.00339	CbGpPWpGaD
Prasugrel—Haematuria—Methotrexate—multiple sclerosis	0.000301	0.00238	CcSEcCtD
Prasugrel—Epistaxis—Methotrexate—multiple sclerosis	0.000298	0.00235	CcSEcCtD
Prasugrel—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000298	0.00235	CcSEcCtD
Prasugrel—CYP2B6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000298	0.00335	CbGpPWpGaD
Prasugrel—CYP2B6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000298	0.00335	CbGpPWpGaD
Prasugrel—Nausea—Azathioprine—multiple sclerosis	0.000297	0.00235	CcSEcCtD
Prasugrel—P2RY12—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.000296	0.00333	CbGpPWpGaD
Prasugrel—Skin disorder—Methylprednisolone—multiple sclerosis	0.000296	0.00234	CcSEcCtD
Prasugrel—Hypertension—Betamethasone—multiple sclerosis	0.000293	0.00231	CcSEcCtD
Prasugrel—Hypertension—Dexamethasone—multiple sclerosis	0.000293	0.00231	CcSEcCtD
Prasugrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000291	0.00328	CbGpPWpGaD
Prasugrel—Asthenia—Mitoxantrone—multiple sclerosis	0.00029	0.00229	CcSEcCtD
Prasugrel—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000286	0.00322	CbGpPWpGaD
Prasugrel—Haemoglobin—Methotrexate—multiple sclerosis	0.000285	0.00225	CcSEcCtD
Prasugrel—Hypotension—Methylprednisolone—multiple sclerosis	0.000284	0.00225	CcSEcCtD
Prasugrel—Haemorrhage—Methotrexate—multiple sclerosis	0.000284	0.00224	CcSEcCtD
Prasugrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000283	0.00319	CbGpPWpGaD
Prasugrel—Urinary tract disorder—Methotrexate—multiple sclerosis	0.00028	0.00221	CcSEcCtD
Prasugrel—Urethral disorder—Methotrexate—multiple sclerosis	0.000278	0.0022	CcSEcCtD
Prasugrel—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000277	0.00219	CcSEcCtD
Prasugrel—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000277	0.00219	CcSEcCtD
Prasugrel—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000277	0.00219	CcSEcCtD
Prasugrel—Anaemia—Prednisone—multiple sclerosis	0.000273	0.00216	CcSEcCtD
Prasugrel—Dyspnoea—Triamcinolone—multiple sclerosis	0.000272	0.00215	CcSEcCtD
Prasugrel—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000271	0.00214	CcSEcCtD
Prasugrel—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000271	0.00214	CcSEcCtD
Prasugrel—Angioedema—Prednisone—multiple sclerosis	0.00027	0.00213	CcSEcCtD
Prasugrel—ALB—Lipoprotein metabolism—APOE—multiple sclerosis	0.000269	0.00303	CbGpPWpGaD
Prasugrel—Eye disorder—Methotrexate—multiple sclerosis	0.000265	0.00209	CcSEcCtD
Prasugrel—Fatigue—Triamcinolone—multiple sclerosis	0.000263	0.00208	CcSEcCtD
Prasugrel—Fatigue—Methylprednisolone—multiple sclerosis	0.000262	0.00207	CcSEcCtD
Prasugrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000261	0.00294	CbGpPWpGaD
Prasugrel—CES2—NRF2 pathway—TGFB1—multiple sclerosis	0.000261	0.00294	CbGpPWpGaD
Prasugrel—Hypotension—Dexamethasone—multiple sclerosis	0.000259	0.00204	CcSEcCtD
Prasugrel—Hypotension—Betamethasone—multiple sclerosis	0.000259	0.00204	CcSEcCtD
Prasugrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000258	0.00291	CbGpPWpGaD
Prasugrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000258	0.00291	CbGpPWpGaD
Prasugrel—Angiopathy—Methotrexate—multiple sclerosis	0.000257	0.00203	CcSEcCtD
Prasugrel—P2RY12—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000256	0.00289	CbGpPWpGaD
Prasugrel—Immune system disorder—Methotrexate—multiple sclerosis	0.000256	0.00202	CcSEcCtD
Prasugrel—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000256	0.00202	CcSEcCtD
Prasugrel—Hypertension—Prednisone—multiple sclerosis	0.000255	0.00201	CcSEcCtD
Prasugrel—Rash—Mitoxantrone—multiple sclerosis	0.000255	0.00201	CcSEcCtD
Prasugrel—Dermatitis—Mitoxantrone—multiple sclerosis	0.000255	0.00201	CcSEcCtD
Prasugrel—P2RY12—G alpha (i) signalling events—CCL5—multiple sclerosis	0.000255	0.00287	CbGpPWpGaD
Prasugrel—Headache—Mitoxantrone—multiple sclerosis	0.000253	0.002	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00025	0.00197	CcSEcCtD
Prasugrel—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000249	0.0028	CbGpPWpGaD
Prasugrel—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000248	0.00279	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—SELE—multiple sclerosis	0.000248	0.00279	CbGpPWpGaD
Prasugrel—Hypersensitivity—Prednisolone—multiple sclerosis	0.000244	0.00193	CcSEcCtD
Prasugrel—Body temperature increased—Triamcinolone—multiple sclerosis	0.000241	0.00191	CcSEcCtD
Prasugrel—Anaphylactic shock—Prednisone—multiple sclerosis	0.000241	0.0019	CcSEcCtD
Prasugrel—Nausea—Mitoxantrone—multiple sclerosis	0.00024	0.0019	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000239	0.00189	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000239	0.00189	CcSEcCtD
Prasugrel—Back pain—Methotrexate—multiple sclerosis	0.000239	0.00189	CcSEcCtD
Prasugrel—Fatigue—Betamethasone—multiple sclerosis	0.000239	0.00189	CcSEcCtD
Prasugrel—Fatigue—Dexamethasone—multiple sclerosis	0.000239	0.00189	CcSEcCtD
Prasugrel—P2RY12—GPCR ligand binding—CCL3—multiple sclerosis	0.000238	0.00269	CbGpPWpGaD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	0.000237	0.00268	CbGpPWpGaD
Prasugrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000235	0.00265	CbGpPWpGaD
Prasugrel—Skin disorder—Prednisone—multiple sclerosis	0.000234	0.00185	CcSEcCtD
Prasugrel—P2RY12—Signaling by GPCR—S1PR1—multiple sclerosis	0.000233	0.00262	CbGpPWpGaD
Prasugrel—P2RY12—GPCR ligand binding—PTGER4—multiple sclerosis	0.000229	0.00259	CbGpPWpGaD
Prasugrel—P2RY12—G alpha (i) signalling events—CCR5—multiple sclerosis	0.000229	0.00259	CbGpPWpGaD
Prasugrel—Anaemia—Methotrexate—multiple sclerosis	0.000228	0.0018	CcSEcCtD
Prasugrel—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000228	0.00257	CbGpPWpGaD
Prasugrel—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000228	0.00257	CbGpPWpGaD
Prasugrel—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000225	0.00253	CbGpPWpGaD
Prasugrel—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000225	0.00253	CbGpPWpGaD
Prasugrel—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000225	0.00178	CcSEcCtD
Prasugrel—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000224	0.00177	CcSEcCtD
Prasugrel—P2RY12—GPCR ligand binding—CXCR3—multiple sclerosis	0.000222	0.0025	CbGpPWpGaD
Prasugrel—Leukopenia—Methotrexate—multiple sclerosis	0.000221	0.00175	CcSEcCtD
Prasugrel—Dizziness—Prednisolone—multiple sclerosis	0.000219	0.00173	CcSEcCtD
Prasugrel—Asthenia—Triamcinolone—multiple sclerosis	0.000219	0.00173	CcSEcCtD
Prasugrel—Body temperature increased—Betamethasone—multiple sclerosis	0.000219	0.00173	CcSEcCtD
Prasugrel—Body temperature increased—Dexamethasone—multiple sclerosis	0.000219	0.00173	CcSEcCtD
Prasugrel—Asthenia—Methylprednisolone—multiple sclerosis	0.000218	0.00173	CcSEcCtD
Prasugrel—P2RY12—GPCR downstream signaling—RGS1—multiple sclerosis	0.000218	0.00246	CbGpPWpGaD
Prasugrel—P2RY12—GPCR ligand binding—CCR2—multiple sclerosis	0.000216	0.00243	CbGpPWpGaD
Prasugrel—Cough—Methotrexate—multiple sclerosis	0.000215	0.0017	CcSEcCtD
Prasugrel—ALB—Vitamin B12 Metabolism—CCL5—multiple sclerosis	0.000215	0.00242	CbGpPWpGaD
Prasugrel—P2RY12—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000213	0.0024	CbGpPWpGaD
Prasugrel—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—multiple sclerosis	0.000209	0.00236	CbGpPWpGaD
Prasugrel—Rash—Prednisolone—multiple sclerosis	0.000209	0.00165	CcSEcCtD
Prasugrel—Dermatitis—Prednisolone—multiple sclerosis	0.000209	0.00165	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000209	0.00165	CcSEcCtD
Prasugrel—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000208	0.00165	CcSEcCtD
Prasugrel—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000208	0.00234	CbGpPWpGaD
Prasugrel—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000208	0.00234	CbGpPWpGaD
Prasugrel—Fatigue—Prednisone—multiple sclerosis	0.000208	0.00164	CcSEcCtD
Prasugrel—Headache—Prednisolone—multiple sclerosis	0.000208	0.00164	CcSEcCtD
Prasugrel—P2RY12—GPCR downstream signaling—GPR65—multiple sclerosis	0.000207	0.00233	CbGpPWpGaD
Prasugrel—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000205	0.00231	CbGpPWpGaD
Prasugrel—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000205	0.00231	CbGpPWpGaD
Prasugrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000202	0.00228	CbGpPWpGaD
Prasugrel—Dizziness—Triamcinolone—multiple sclerosis	0.000202	0.00159	CcSEcCtD
Prasugrel—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000201	0.00159	CcSEcCtD
Prasugrel—Dizziness—Methylprednisolone—multiple sclerosis	0.000201	0.00159	CcSEcCtD
Prasugrel—P2RY12—GPCR ligand binding—CNR1—multiple sclerosis	0.000199	0.00224	CbGpPWpGaD
Prasugrel—Asthenia—Dexamethasone—multiple sclerosis	0.000199	0.00157	CcSEcCtD
Prasugrel—Asthenia—Betamethasone—multiple sclerosis	0.000199	0.00157	CcSEcCtD
Prasugrel—P2RY12—Signaling by GPCR—RGS1—multiple sclerosis	0.000198	0.00223	CbGpPWpGaD
Prasugrel—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000197	0.00156	CcSEcCtD
Prasugrel—Nausea—Prednisolone—multiple sclerosis	0.000197	0.00156	CcSEcCtD
Prasugrel—ALB—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000196	0.00221	CbGpPWpGaD
Prasugrel—Skin disorder—Methotrexate—multiple sclerosis	0.000196	0.00155	CcSEcCtD
Prasugrel—Rash—Triamcinolone—multiple sclerosis	0.000192	0.00152	CcSEcCtD
Prasugrel—Dermatitis—Triamcinolone—multiple sclerosis	0.000192	0.00152	CcSEcCtD
Prasugrel—Rash—Methylprednisolone—multiple sclerosis	0.000192	0.00152	CcSEcCtD
Prasugrel—Dermatitis—Methylprednisolone—multiple sclerosis	0.000192	0.00151	CcSEcCtD
Prasugrel—Headache—Triamcinolone—multiple sclerosis	0.000191	0.00151	CcSEcCtD
Prasugrel—Headache—Methylprednisolone—multiple sclerosis	0.000191	0.00151	CcSEcCtD
Prasugrel—Body temperature increased—Prednisone—multiple sclerosis	0.000191	0.00151	CcSEcCtD
Prasugrel—Diarrhoea—Betamethasone—multiple sclerosis	0.000189	0.0015	CcSEcCtD
Prasugrel—Diarrhoea—Dexamethasone—multiple sclerosis	0.000189	0.0015	CcSEcCtD
Prasugrel—P2RY12—GPCR downstream signaling—CCR1—multiple sclerosis	0.000189	0.00213	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000189	0.00213	CbGpPWpGaD
Prasugrel—Hypotension—Methotrexate—multiple sclerosis	0.000188	0.00149	CcSEcCtD
Prasugrel—P2RY12—Signaling by GPCR—GPR65—multiple sclerosis	0.000188	0.00211	CbGpPWpGaD
Prasugrel—Dizziness—Betamethasone—multiple sclerosis	0.000183	0.00145	CcSEcCtD
Prasugrel—Dizziness—Dexamethasone—multiple sclerosis	0.000183	0.00145	CcSEcCtD
Prasugrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000182	0.00206	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—LINGO1—multiple sclerosis	0.000181	0.00205	CbGpPWpGaD
Prasugrel—Nausea—Triamcinolone—multiple sclerosis	0.000181	0.00143	CcSEcCtD
Prasugrel—Nausea—Methylprednisolone—multiple sclerosis	0.000181	0.00143	CcSEcCtD
Prasugrel—Dyspnoea—Methotrexate—multiple sclerosis	0.00018	0.00142	CcSEcCtD
Prasugrel—P2RY12—G alpha (i) signalling events—POMC—multiple sclerosis	0.000179	0.00202	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—ITGA4—multiple sclerosis	0.000179	0.00202	CbGpPWpGaD
Prasugrel—P2RY12—GPCR ligand binding—CXCL10—multiple sclerosis	0.000179	0.00202	CbGpPWpGaD
Prasugrel—ALB—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	0.000179	0.00201	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—IFNB1—multiple sclerosis	0.000178	0.002	CbGpPWpGaD
Prasugrel—Hypersensitivity—Prednisone—multiple sclerosis	0.000178	0.0014	CcSEcCtD
Prasugrel—ALB—Vitamin B12 Metabolism—APOE—multiple sclerosis	0.000176	0.00198	CbGpPWpGaD
Prasugrel—Rash—Betamethasone—multiple sclerosis	0.000175	0.00138	CcSEcCtD
Prasugrel—Rash—Dexamethasone—multiple sclerosis	0.000175	0.00138	CcSEcCtD
Prasugrel—Dermatitis—Dexamethasone—multiple sclerosis	0.000174	0.00138	CcSEcCtD
Prasugrel—Dermatitis—Betamethasone—multiple sclerosis	0.000174	0.00138	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000174	0.00137	CcSEcCtD
Prasugrel—Fatigue—Methotrexate—multiple sclerosis	0.000174	0.00137	CcSEcCtD
Prasugrel—Headache—Dexamethasone—multiple sclerosis	0.000173	0.00137	CcSEcCtD
Prasugrel—Headache—Betamethasone—multiple sclerosis	0.000173	0.00137	CcSEcCtD
Prasugrel—Asthenia—Prednisone—multiple sclerosis	0.000173	0.00137	CcSEcCtD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.000172	0.00193	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—CCR1—multiple sclerosis	0.000172	0.00193	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—CXCL13—multiple sclerosis	0.000172	0.00193	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.000169	0.00191	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—IL4—multiple sclerosis	0.000169	0.00191	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	0.000165	0.00186	CbGpPWpGaD
Prasugrel—Diarrhoea—Prednisone—multiple sclerosis	0.000165	0.0013	CcSEcCtD
Prasugrel—Nausea—Dexamethasone—multiple sclerosis	0.000164	0.0013	CcSEcCtD
Prasugrel—Nausea—Betamethasone—multiple sclerosis	0.000164	0.0013	CcSEcCtD
Prasugrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000164	0.00185	CbGpPWpGaD
Prasugrel—Dizziness—Prednisone—multiple sclerosis	0.000159	0.00126	CcSEcCtD
Prasugrel—Body temperature increased—Methotrexate—multiple sclerosis	0.000159	0.00126	CcSEcCtD
Prasugrel—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000158	0.00178	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TAGAP—multiple sclerosis	0.000157	0.00177	CbGpPWpGaD
Prasugrel—P2RY12—GPCR ligand binding—CCL5—multiple sclerosis	0.000154	0.00174	CbGpPWpGaD
Prasugrel—Rash—Prednisone—multiple sclerosis	0.000152	0.0012	CcSEcCtD
Prasugrel—Dermatitis—Prednisone—multiple sclerosis	0.000152	0.0012	CcSEcCtD
Prasugrel—Headache—Prednisone—multiple sclerosis	0.000151	0.00119	CcSEcCtD
Prasugrel—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000149	0.00168	CbGpPWpGaD
Prasugrel—Hypersensitivity—Methotrexate—multiple sclerosis	0.000148	0.00117	CcSEcCtD
Prasugrel—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	0.000148	0.00167	CbGpPWpGaD
Prasugrel—Asthenia—Methotrexate—multiple sclerosis	0.000145	0.00114	CcSEcCtD
Prasugrel—Nausea—Prednisone—multiple sclerosis	0.000143	0.00113	CcSEcCtD
Prasugrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000143	0.00161	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—MERTK—multiple sclerosis	0.000141	0.00159	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—CD58—multiple sclerosis	0.000141	0.00159	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—SELPLG—multiple sclerosis	0.000141	0.00159	CbGpPWpGaD
Prasugrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000139	0.00157	CbGpPWpGaD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.000139	0.00157	CbGpPWpGaD
Prasugrel—P2RY12—GPCR ligand binding—CCR5—multiple sclerosis	0.000139	0.00157	CbGpPWpGaD
Prasugrel—Diarrhoea—Methotrexate—multiple sclerosis	0.000138	0.00109	CcSEcCtD
Prasugrel—P2RY12—Signaling Pathways—S1PR1—multiple sclerosis	0.000138	0.00155	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000137	0.00154	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000137	0.00154	CbGpPWpGaD
Prasugrel—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000135	0.00152	CbGpPWpGaD
Prasugrel—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000135	0.00152	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—ICAM1—multiple sclerosis	0.000134	0.00151	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—GPC5—multiple sclerosis	0.000134	0.00151	CbGpPWpGaD
Prasugrel—Dizziness—Methotrexate—multiple sclerosis	0.000133	0.00105	CcSEcCtD
Prasugrel—P2RY12—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00013	0.00146	CbGpPWpGaD
Prasugrel—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000128	0.00144	CbGpPWpGaD
Prasugrel—Rash—Methotrexate—multiple sclerosis	0.000127	0.001	CcSEcCtD
Prasugrel—Dermatitis—Methotrexate—multiple sclerosis	0.000127	0.001	CcSEcCtD
Prasugrel—Headache—Methotrexate—multiple sclerosis	0.000126	0.000997	CcSEcCtD
Prasugrel—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	0.000126	0.00142	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000125	0.00141	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—IL2RA—multiple sclerosis	0.000122	0.00138	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—CCL3—multiple sclerosis	0.000122	0.00138	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—CCR2—multiple sclerosis	0.000122	0.00137	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—CCL2—multiple sclerosis	0.00012	0.00136	CbGpPWpGaD
Prasugrel—Nausea—Methotrexate—multiple sclerosis	0.00012	0.000945	CcSEcCtD
Prasugrel—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000119	0.00134	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—PTGER4—multiple sclerosis	0.000118	0.00133	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—RGS1—multiple sclerosis	0.000117	0.00132	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—CXCR3—multiple sclerosis	0.000114	0.00128	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—CNR1—multiple sclerosis	0.000112	0.00127	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	0.000112	0.00126	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—GPR65—multiple sclerosis	0.000111	0.00125	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—CCR2—multiple sclerosis	0.000111	0.00125	CbGpPWpGaD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.000109	0.00122	CbGpPWpGaD
Prasugrel—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000109	0.00122	CbGpPWpGaD
Prasugrel—P2RY12—GPCR ligand binding—POMC—multiple sclerosis	0.000109	0.00122	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000107	0.0012	CbGpPWpGaD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.000106	0.0012	CbGpPWpGaD
Prasugrel—P2RY12—GPCR ligand binding—CCL2—multiple sclerosis	0.000106	0.0012	CbGpPWpGaD
Prasugrel—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000104	0.00117	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—IFNG—multiple sclerosis	0.000102	0.00115	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—CNR1—multiple sclerosis	0.000102	0.00115	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CXCL13—multiple sclerosis	0.000101	0.00114	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CCR1—multiple sclerosis	0.000101	0.00114	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000101	0.00114	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.97e-05	0.00112	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.75e-05	0.0011	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.75e-05	0.0011	CbGpPWpGaD
Prasugrel—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.65e-05	0.00109	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	9.55e-05	0.00108	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—CXCL10—multiple sclerosis	9.19e-05	0.00104	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—IL1B—multiple sclerosis	9.12e-05	0.00103	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—IL2—multiple sclerosis	9.09e-05	0.00102	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—ALB—multiple sclerosis	8.85e-05	0.000997	CbGpPWpGaD
Prasugrel—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.8e-05	0.000992	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.75e-05	0.000986	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.75e-05	0.000986	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PLEK—multiple sclerosis	8.73e-05	0.000984	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—CCL5—multiple sclerosis	8.71e-05	0.000982	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	8.13e-05	0.000917	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	8.12e-05	0.000915	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.98e-05	0.000899	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.98e-05	0.000899	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—CCL5—multiple sclerosis	7.91e-05	0.000892	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—CCR5—multiple sclerosis	7.85e-05	0.000885	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—IL2RA—multiple sclerosis	7.74e-05	0.000872	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.56e-05	0.000852	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—SRM—multiple sclerosis	7.32e-05	0.000825	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	7.25e-05	0.000817	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CCL3—multiple sclerosis	7.23e-05	0.000814	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—IL2—multiple sclerosis	7.18e-05	0.000809	CbGpPWpGaD
Prasugrel—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.16e-05	0.000807	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—CCR5—multiple sclerosis	7.13e-05	0.000803	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—IL2RA—multiple sclerosis	7.03e-05	0.000792	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PTGER4—multiple sclerosis	6.96e-05	0.000784	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PGR—multiple sclerosis	6.85e-05	0.000772	CbGpPWpGaD
Prasugrel—CYP2B6—Biological oxidations—POMC—multiple sclerosis	6.79e-05	0.000765	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CXCR3—multiple sclerosis	6.72e-05	0.000757	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CD28—multiple sclerosis	6.65e-05	0.00075	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—TNF—multiple sclerosis	6.62e-05	0.000746	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	6.56e-05	0.00074	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CCR2—multiple sclerosis	6.53e-05	0.000736	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SRM—multiple sclerosis	6.16e-05	0.000695	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—SELE—multiple sclerosis	6.15e-05	0.000693	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—POMC—multiple sclerosis	6.13e-05	0.000691	CbGpPWpGaD
Prasugrel—ALB—Platelet degranulation—TGFB1—multiple sclerosis	6.08e-05	0.000685	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CNR1—multiple sclerosis	6.03e-05	0.00068	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.98e-05	0.000673	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	5.89e-05	0.000664	CbGpPWpGaD
Prasugrel—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.81e-05	0.000654	CbGpPWpGaD
Prasugrel—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	5.79e-05	0.000652	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—TGFB1—multiple sclerosis	5.6e-05	0.000631	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—POMC—multiple sclerosis	5.57e-05	0.000628	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SRM—multiple sclerosis	5.53e-05	0.000624	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—MAPK1—multiple sclerosis	5.49e-05	0.000619	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—CCL2—multiple sclerosis	5.45e-05	0.000614	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CXCL10—multiple sclerosis	5.43e-05	0.000612	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—IL6—multiple sclerosis	5.34e-05	0.000602	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.28e-05	0.000595	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	5.26e-05	0.000593	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	5.16e-05	0.000581	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	5.16e-05	0.000581	CbGpPWpGaD
Prasugrel—CYP2C19—Biological oxidations—POMC—multiple sclerosis	5.13e-05	0.000578	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SRM—multiple sclerosis	5.05e-05	0.000569	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—TYK2—multiple sclerosis	4.95e-05	0.000558	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CD86—multiple sclerosis	4.75e-05	0.000535	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GPC5—multiple sclerosis	4.72e-05	0.000532	CbGpPWpGaD
Prasugrel—CYP2C9—Biological oxidations—POMC—multiple sclerosis	4.68e-05	0.000527	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CCL5—multiple sclerosis	4.67e-05	0.000527	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—IL2—multiple sclerosis	4.54e-05	0.000511	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—ITGA4—multiple sclerosis	4.45e-05	0.000501	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IFNB1—multiple sclerosis	4.42e-05	0.000498	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP27B1—multiple sclerosis	4.34e-05	0.000489	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP24A1—multiple sclerosis	4.34e-05	0.000489	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SPP1—multiple sclerosis	4.33e-05	0.000488	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.24e-05	0.000478	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	4.24e-05	0.000478	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CCR5—multiple sclerosis	4.21e-05	0.000474	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IL2RA—multiple sclerosis	4.15e-05	0.000468	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—IL2—multiple sclerosis	4.12e-05	0.000464	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GPC5—multiple sclerosis	3.97e-05	0.000448	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—RRM1—multiple sclerosis	3.91e-05	0.000441	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.9e-05	0.000439	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.9e-05	0.000439	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—APOE—multiple sclerosis	3.83e-05	0.000432	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.81e-05	0.000429	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.57e-05	0.000402	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	3.55e-05	0.000401	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	3.55e-05	0.000401	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.47e-05	0.000392	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CD80—multiple sclerosis	3.46e-05	0.00039	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	3.46e-05	0.000389	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SRM—multiple sclerosis	3.33e-05	0.000375	CbGpPWpGaD
Prasugrel—ALB—Metabolism—RRM1—multiple sclerosis	3.29e-05	0.000371	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—POMC—multiple sclerosis	3.29e-05	0.000371	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GPC5—multiple sclerosis	3.25e-05	0.000366	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CCL2—multiple sclerosis	3.22e-05	0.000363	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—MAPK1—multiple sclerosis	3.15e-05	0.000355	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.08e-05	0.000347	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IL2RA—multiple sclerosis	3.04e-05	0.000342	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.95e-05	0.000333	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TYK2—multiple sclerosis	2.92e-05	0.000329	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	2.7e-05	0.000304	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.69e-05	0.000304	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	2.64e-05	0.000298	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.55e-05	0.000288	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IL2—multiple sclerosis	2.43e-05	0.000274	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—IL6—multiple sclerosis	2.42e-05	0.000273	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.34e-05	0.000264	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.34e-05	0.000264	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MMP9—multiple sclerosis	2.3e-05	0.000259	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.29e-05	0.000258	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.25e-05	0.000253	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.19e-05	0.000247	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.14e-05	0.000242	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.09e-05	0.000236	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—STAT3—multiple sclerosis	2.05e-05	0.000231	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.97e-05	0.000222	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MYC—multiple sclerosis	1.9e-05	0.000214	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TGFB1—multiple sclerosis	1.9e-05	0.000214	CbGpPWpGaD
Prasugrel—ALB—Metabolism—BCHE—multiple sclerosis	1.89e-05	0.000213	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MAPK1—multiple sclerosis	1.86e-05	0.00021	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.8e-05	0.000202	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.8e-05	0.000202	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IL2—multiple sclerosis	1.78e-05	0.000201	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.78e-05	0.0002	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.7e-05	0.000191	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.64e-05	0.000184	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.55e-05	0.000174	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IL6—multiple sclerosis	1.43e-05	0.000161	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TGFB1—multiple sclerosis	1.39e-05	0.000157	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—MAPK1—multiple sclerosis	1.36e-05	0.000154	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—APOE—multiple sclerosis	1.35e-05	0.000152	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—POMC—multiple sclerosis	1.16e-05	0.000131	CbGpPWpGaD
Prasugrel—ALB—Metabolism—APOE—multiple sclerosis	1.14e-05	0.000128	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ALB—multiple sclerosis	1.06e-05	0.000119	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—APOE—multiple sclerosis	1.02e-05	0.000115	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.02e-05	0.000115	CbGpPWpGaD
Prasugrel—ALB—Metabolism—POMC—multiple sclerosis	9.77e-06	0.00011	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—APOE—multiple sclerosis	9.31e-06	0.000105	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—POMC—multiple sclerosis	8.77e-06	9.88e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—POMC—multiple sclerosis	8e-06	9.01e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ALB—multiple sclerosis	8e-06	9.01e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ALB—multiple sclerosis	7.29e-06	8.22e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—APOE—multiple sclerosis	6.14e-06	6.92e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—POMC—multiple sclerosis	5.27e-06	5.94e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALB—multiple sclerosis	4.81e-06	5.42e-05	CbGpPWpGaD
